Frank M.  Fischer net worth and biography

Frank Fischer Biography and Net Worth

Director of NeuroPace
Frank Fischer has served as the Chairman of our board of directors since November 1997. From 2000 to July 2019, Mr. Fischer served as our President and Chief Executive Officer and as a part-time employee of ours from July 2019 to January 2020. Prior to that, Mr. Fischer was President and Chief Executive Officer of Heartport, Inc., a medical device company, from 1998 to 1999, and served on Heartport’s board of directors from 1992 to 1999. Previously, Mr. Fischer was President and Chief Executive Officer of Ventritex, Inc., a company that pioneered implantable cardiac defibrillators, from 1987 until the sale of the company to St. Jude Medical, Inc. in 1997. Mr. Fischer has served as a member of the board of directors of Nevro, Inc., a medical device company, since 2012. Mr. Fischer received a B.S. in Mechanical Engineering and a M.S. in Management from Rensselaer Polytechnic Institute. We believe Mr. Fischer is qualified to serve on our board of directors because of his extensive experience with medical device companies and the historical knowledge and continuity he brings to our board of directors.

What is Frank M. Fischer's net worth?

The estimated net worth of Frank M. Fischer is at least $904,922.70 as of April 21st, 2021. Mr. Fischer owns 93,291 shares of NeuroPace stock worth more than $904,923 as of November 23rd. This net worth approximation does not reflect any other investments that Mr. Fischer may own. Learn More about Frank M. Fischer's net worth.

How do I contact Frank M. Fischer?

The corporate mailing address for Mr. Fischer and other NeuroPace executives is , , . NeuroPace can also be reached via phone at 650-237-2700 and via email at [email protected]. Learn More on Frank M. Fischer's contact information.

Has Frank M. Fischer been buying or selling shares of NeuroPace?

Frank M. Fischer has not been actively trading shares of NeuroPace during the past quarter. Most recently, on Wednesday, April 21st, Frank M. Fischer bought 50,000 shares of NeuroPace stock. The stock was acquired at an average cost of $17.00 per share, with a total value of $850,000.00. Following the completion of the transaction, the director now directly owns 93,291 shares of the company's stock, valued at $1,585,947. Learn More on Frank M. Fischer's trading history.

Who are NeuroPace's active insiders?

NeuroPace's insider roster includes Frank Fischer (Director), and Irina Ridley (General Counsel). Learn More on NeuroPace's active insiders.

Are insiders buying or selling shares of NeuroPace?

In the last twelve months, insiders at the sold shares 24 times. They sold a total of 813,294 shares worth more than $9,303,620.65. The most recent insider tranaction occured on October, 25th when Major Shareholder Ltd. Kck sold 223,991 shares worth more than $1,220,750.95. Insiders at NeuroPace own 22.2% of the company. Learn More about insider trades at NeuroPace.

Information on this page was last updated on 10/25/2024.

Frank M. Fischer Insider Trading History at NeuroPace

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/21/2021Buy50,000$17.00$850,000.0093,291View SEC Filing Icon  
See Full Table

Frank M. Fischer Buying and Selling Activity at NeuroPace

This chart shows Frank M Fischer's buying and selling at NeuroPace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeuroPace Company Overview

NeuroPace logo
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Read More

Today's Range

Now: $9.70
Low: $8.91
High: $9.70

50 Day Range

MA: $7.13
Low: $5.90
High: $9.70

2 Week Range

Now: $9.70
Low: $5.45
High: $18.15

Volume

67,025 shs

Average Volume

120,334 shs

Market Capitalization

$289.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79